Serenis

Private

MilanHealthcare & Life Scienceshttps://www.serenis.it/

Last Round

Series A

Sep 29, 2025

Total Funding Raised

$19.64M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Serenis is a digital health company that provides an online platform for mental health services, including psychotherapy, psychiatry, nutrition, and coaching.

Sector

Healthcare & Life Sciences

Verticals

Mental Health, Telemedicine, HR

Business Model

B2C

Customer Profile

Usage-Based SaaS, Subscription SaaS

AI Layer

Application

Keywords

online psychotherapytelemedicinemental health supportteletherapyemployee well-beingEAPemployee assistance programdigital healthremote counselingcorporate mental healthmental health benefitsgenerative AIAI scribe

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Serenis Comparables

Compare Serenis with similar companies based on industry and business-model similarity.

Serenis comparables — related companies by embedding similarity
Company	Similarity	Market Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Serenis Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Sep 29, 2025
Seed	Nov 10, 2022
Pre Seed	Feb 8, 2022

View all Funding Rounds

Key People

Founding team and executive leadership

Silvia Wang

Co-Founder CEO

Founding Team

Serena Rossetti

CFO

Executive Team

Ettore Penazzato

COO

Executive Team

Carlo Alberto Gaetaniello

Chief Product Officer, Director Of Business Development

Executive Team

View all key people

Serenis Investors

Notable investors and investment history

Serenis investors
Investor	Rounds
Azimut Libera Impresa SGR	Seed, Series A
FG2 Capital	Series A, Seed
Club degli Investitori	Series A
Invictus Capital Partners (Singapore)	Seed, Series A
Lumen Ventures	Seed, Series A
Angelini Ventures	Seed, Series A
CDP Venture Capital SGR	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Dec 22, 2025
Added Unifarco S.p.A. from the Pharmaceuticals/Cosmetics industry.
Oct 1, 2025
Launched Serenis Studio for in-person therapy sessions.

View all signals

Serenis Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Serenis Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Serenis's valuation, stock price, and market status.

Firmographic Details

HeadquartersMilan

Employee Range800

Year Founded2021

Last FundingSep 29, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.